Edifice Health Revenue and Competitors

Edifice Health's mission is to decrease the incidence and prevalence of chronic diseases and to improve aging worldwide. We focus on the identification of immune system biomarkers of aging and related diseases for the discovery of interventions to delay and prevent major chronic diseases. The Inflammatory Age® is the first commercially available test to measure systemic chronic inflammation (SCI), the root cause of most age-related disease. Headquartered in San Mateo, California, Edifice Health is a digital health / AI spin-out company from the 10-year research initiative from Stanford University, the Stanford 1,000 Immunomes Project, which monitored a wealth of biomarkers for aging of the immune system. Using AI approaches, the results of the data collected derived the first metric to measure systemic chronic inflammation and the degree of a weakened immunity which predicts cumulative chronic diseases. http://med.stanford.edu/1000immunomes.html Edifice Health Inc.